News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
284 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (164)
2 (27)
3 (38)
4 (284)
5 (268)
6 (206)
7 (197)
8 (98)
9 (4)
10 (7)
11 (190)
12 (219)
13 (201)
14 (199)
15 (83)
16 (9)
17 (6)
18 (182)
19 (259)
20 (94)
21 (65)
22 (40)
23 (1)
24 (3)
25 (64)
26 (61)
27 (54)
28 (44)
29 (94)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
TILT Biotherapeutics Wins a Grant from European Commission for a Phase 1 Clinical Trial
TILT Biotherapeutics Ltd has won a grant for a 2.5 M€ (~$ 2.9M) project, entitled UNLEASHAD, from the European Commission EIC SME Instrument.
June 4, 2018
·
2 min read
BioMidwest
AbbVie Announces Final Results of Modified Dutch Auction Tender Offer
AbbVie announced the final results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018.
June 4, 2018
·
2 min read
BioMidwest
Leica Microsystems Announces New Market Representation for Southern California Medical Market
Leica Microsystems announces new market representation for its neurosurgical, spine, ophthalmic, otolaryngologic, dental and plastic reconstructive microscope sales in Southern California.
June 4, 2018
·
2 min read
Bio NC
2018 “Be Their Muscle” Nationwide Philanthropic Event
Burn Boot Camp, a nationwide health & fitness franchise teams up with the MDA for their third annual “Be Their Muscle” philanthropic event to benefit the MDA.
June 4, 2018
·
1 min read
Drug Development
Two-Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with BAVENCIO® (avelumab)
Merck KGaA, Darmstadt, Germany and Pfizer Inc. announced that updated efficacy and safety data from the pivotal JAVELIN Merkel 200 trial of BAVENCIO(R) (avelumab) in patients with metastatic Merkel cell carcinoma (mMCC), will be presented as an oral abstract session at the 54th American Society of Clinical Oncology (ASCO) Annual Meeting.
June 4, 2018
·
20 min read
Drug Development
MEI Pharma Presents Clinical Data for ME-344 in HER2 Negative Breast Cancer Patients at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
MEI Pharma, Inc. announced that data presented at ASCO 2018 from an investigator-initiated study of ME-344 in patients with HER2 negative breast cancer demonstrate evidence of inhibition of tumor proliferation as measured by Ki-67 reductions.
June 4, 2018
·
6 min read
Drug Development
OncoSec Presents Update on PISCES/KEYNOTE-695 Phase 2b Registration-Directed Clinical Trial in Combination with Merck’s KEYTRUDA® for Metastatic Melanoma at the ASCO 2018 Annual Meeting
OncoSec Medical Incorporated announced the presentation of a Trials in Progress poster at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting taking place in Chicago, IL.
June 4, 2018
·
5 min read
Pharm Country
Ocean State Healthcare, a Management Services Company for Providers of Urgent Care, Primary Care and Related Healthcare Services Acquires Newport County Medical Treatment Office
Providence-based Ocean State Healthcare acquired Newport County Medical Treatment Office, a single site Urgent Care Center.
June 4, 2018
·
1 min read
Deals
Ipsen initiates a share buyback program to cover its free share allocation and employee share plans
Ipsen announces that it has appointed an investment services provider to purchase 250,000 Ipsen SA shares, or about 0.30% of the share capital, over a period of at least 3 months.
June 4, 2018
·
5 min read
Biotech Beach
New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
Masimo announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®) to intermittent and invasive lab hemoglobin (LabHb) in reflecting iatrogenic hemodilution during incremental fluid administration of patients undergoing major surgery.
June 4, 2018
·
8 min read
Previous
4 of 29
Next